 |
인쇄하기
취소
|
KFDA warns possible cardiovascular events over 56 anti-obesity drugs
Over 56 drug companies marketing anti-obesity drug sibutramine under a variety of brand names are likely to soon face a ban on selling the medicine.
The Korea Food and Drug Administration will initiate steps to ascertain the safety profile of the medicine. KFDA started the probe after an expert committee of European Medicine
Agency (EMA) recommended complete withdrawal of the drug from Eu...
The Korea Food and Drug Administration will initiate steps to ascertain the safety profile of the medicine. KFDA started the probe after an expert committee of European Medicine
Agency (EMA) recommended complete withdrawal of the drug from Eu...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.